Ruben Carrasco, MD PhD
Dana-Farber Cancer Institute
Dr. Carrasco earned his MD and PhD degrees at the University of Chile. Motivated by his desire to practice medicine at the highest level, he immigrated to the USA and pursued a residency in anatomic pathology at the Massachusetts General Hospital followed by a fellowship in hematopathology at the Brigham and Women’s Hospital. In recognition to his research accomplishments in the field of multiple myeloma (MM) during his postdoctoral training he was recruited to the Dana-Farber Cancer Institute to develop an independent laboratory research program in MM. Dr. Carrasco is current Professor in Pathology at Harvard Medical School. His principal area of excellence is laboratory and clinical investigation focusing on understanding the roles of the Wnt/b-catenin signaling pathway in MM pathogenesis, with the threefold intent of (i) identifying novel therapeutic targets, (ii) developing novel targeted therapies, and (iii) developing animal models for preclinical and clinical intervention.